"10.1371_journal.pone.0153019","plos one","2016-04-12T00:00:00Z","Sarah V Maifeld; Bodrey Ro; Hoyin Mok; Marla Chu; Li Yu; Ryan Yamagata; Tansy Leonardson; Vera Chio; Bandita Parhy; Samuel Park; Marcia Carlson; Shushil Machhi; Nancy Ulbrandt; Ann R Falsey; Edward E Walsh; C Kathy Wang; Mark T Esser; Fengrong Zuo","Applied Immunology and Microbiology, MedImmune, Mountain View, California, United States of America; Non-clinical Biostatistics, MedImmune, Gaithersburg, Maryland, United States of America; Vaccine and Analytical Sciences, MedImmune, Mountain View, California, United States of America; Purification Process Sciences, MedImmune, Gaithersburg, Maryland, United States of America; Cell Culture and Fermentation Sciences, MedImmune, Gaithersburg, Maryland, United States of America; Department of Infectious Disease and Vaccines, Gaithersburg, California, United States of America; Department of Medicine, University of Rochester School of Medicine and Dentistry, and Department of Medicine, Rochester General Hospital, Rochester, New York, United States of America; Translational Medicine, MedImmune, Gaithersburg, Maryland, United States of America","Conceived and designed the experiments: SVM BR HM M. Chu AF EW CKW FZ. Performed the experiments: SVM BR HM M. Chu TL BP SP. Analyzed the data: SVM BR HM M. Chu LY RY TL VC ARF CKW FZ. Contributed reagents/materials/analysis tools: VC M. Carlson SM NU ARF EEW. Wrote the paper: SVM BR. Critically reviewed the manuscript: SVM BR HM M. Chu LY NU ARF EEW CKW MTE FZ.","The authors of this manuscript have read the journals policy and have the following competing interests. SVM, BR, HM, M. Chu, LY, RY, TL, VC, BP, SP, M. Carlson, SM, NU, CKW, MTE and FZ are current or past employees of MedImmune. ARF receives research funding from ADMA Biologics, MedImmune, AstraZeneca and Sanofi Pasteur. EEW receives research funding from Gilead and MedImmune. ARF serves on advisory boards for Janssen GlaxoSmithKline, Novartis and Merck. EEW provides consulting services to GlaxoSmithKline, Alios Biopharma and Gilead. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","04","Sarah V Maifeld","SVM",18,TRUE,4,4,4,2,TRUE,TRUE,TRUE,10,"5;6;7;9;10;13;14;15;16;18",TRUE
